Ítem
Solo Metadatos

A Cost-of-Illness Study of Patients with HIV/AIDS in Bogotá, Colombia

dc.creatorKuhlmann, Julienspa
dc.creatorKeaei, Mussaspa
dc.creatorConde, Rafaelspa
dc.creatorEvers, Silvia M.A.A.spa
dc.creatorGonzález Rodríguez, Javier Leonardo
dc.creatorGovers, Markspa
dc.creatorHiligsmann, Mickaelspa
dc.date.accessioned2020-05-26T00:02:17Z
dc.date.available2020-05-26T00:02:17Z
dc.date.created2017spa
dc.description.abstractBackground In 2014, 0.3% of the total population in Colombia was living with HIV/AIDS. The data currently available regarding the costs of these patients are very limited. Objectives To estimate the societal costs of patients with HIV/AIDS in Bogotá, Colombia. Methods This study is a quantitative, cross-sectional cost-of-illness study. Costs were assessed with a prevalence-based, bottom-up approach. The data of 124 patients were collected from their medical records in a Bogotá hospital and a questionnaire was developed to measure other health care costs, as well as patient and family costs. Subgroup analyses were performed according to sex, age, Centers for Disease Control and Prevention classification, and CD4 count (cluster of differentiation 4). Results The mean annual cost per patient with HIV/AIDS was estimated at $11,505 ± 18,658 (2014 US dollars). The larger part was attributable to drug costs (a mean annual cost of $8,616, 75% of the total), whereas productivity costs represented a mean annual cost of $1,044 (10%). Total costs per patient were estimated for a CD4 count of 500 or more, 200 to 499, and less than 200 cells/µl at $13,116, $9,077, and $10,741, respectively (all values in 2014 US dollars). Conclusions HIV/AIDS represents a high societal burden in Colombia. In comparison with the gross domestic product per capita of $7,904 in 2014, the mean annual cost per patient with HIV/AIDS was 40% higher, estimated at $11,505. The largest part of the HIV/AIDS costs was attributed to drugs, followed by productivity costs. Using extrapolation, the total cost of HIV/AIDS for the Colombian society would be $1.431 billion. © 2017eng
dc.format.mimetypeapplication/pdf
dc.identifier.doihttps://doi.org/10.1016/j.vhri.2017.09.002
dc.identifier.issn22121099
dc.identifier.issn22121102
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/23468
dc.language.isoengspa
dc.publisherElsevier Inc.spa
dc.relation.citationEndPage107
dc.relation.citationStartPage103
dc.relation.citationTitleValue in Health Regional Issues
dc.relation.citationVolumeVol. 14
dc.relation.ispartofValue in Health Regional Issues, ISSN:22121099, 22121102, Vol.14,(2017); pp. 103-107spa
dc.relation.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85032711126&doi=10.1016%2fj.vhri.2017.09.002&partnerID=40&md5=43e4dd3c703ca30516bb1f6c59ab1d0cspa
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.rights.accesoAbierto (Texto Completo)spa
dc.source.instnameinstname:Universidad del Rosariospa
dc.source.reponamereponame:Repositorio Institucional EdocURspa
dc.subject.keywordAntiretrovirus agentspa
dc.subject.keywordAbsenteeismspa
dc.subject.keywordAcquired immune deficiency syndromespa
dc.subject.keywordAdultspa
dc.subject.keywordArticlespa
dc.subject.keywordCd4 lymphocyte countspa
dc.subject.keywordColombiaspa
dc.subject.keywordCost of illnessspa
dc.subject.keywordCross-sectional studyspa
dc.subject.keywordDrug costspa
dc.subject.keywordFemalespa
dc.subject.keywordHealth care costspa
dc.subject.keywordHospital costspa
dc.subject.keywordHumanspa
dc.subject.keywordHuman immunodeficiency virus infectionspa
dc.subject.keywordMajor clinical studyspa
dc.subject.keywordMalespa
dc.subject.keywordPriority journalspa
dc.subject.keywordProductivityspa
dc.subject.keywordQuantitative studyspa
dc.subject.keywordAcquired immune deficiency syndromespa
dc.subject.keywordEconomicsspa
dc.subject.keywordMiddle agedspa
dc.subject.keywordQuestionnairespa
dc.subject.keywordStatistics and numerical dataspa
dc.subject.keywordAcquired immunodeficiency syndromespa
dc.subject.keywordColombiaspa
dc.subject.keywordCost of illnessspa
dc.subject.keywordCross-sectional studiesspa
dc.subject.keywordDrug costsspa
dc.subject.keywordEfficiencyspa
dc.subject.keywordFemalespa
dc.subject.keywordHealth care costsspa
dc.subject.keywordHumansspa
dc.subject.keywordMalespa
dc.subject.keywordMiddle agedspa
dc.subject.keywordSurveys and questionnairesspa
dc.subject.keywordAidsspa
dc.subject.keywordBurdenspa
dc.subject.keywordColombiaspa
dc.subject.keywordCost of illnessspa
dc.subject.keywordEconomicspa
dc.subject.keywordHivspa
dc.titleA Cost-of-Illness Study of Patients with HIV/AIDS in Bogotá, Colombiaspa
dc.typearticleeng
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersion
dc.type.spaArtículospa
Archivos
Colecciones